BlackRock’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

BlackRock’s Portfolio MIRO Stock Details MIRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-56,042	Closed	-$73.4K	–	5487
2023 Q3	$73.4K	Sell	56,042 -2,233	-4%	-$3.26K	﹤0.01%	4921
2023 Q2	$102K	Buy	58,275 +18,372	+46%	+$24.2K	﹤0.01%	4906
2023 Q1	$67K	Buy	39,903 +1,248	+3%	+$3.24K	﹤0.01%	5058
2022 Q4	$116K	Buy	38,655 +1,033	+3%	+$4.05K	﹤0.01%	4994
2022 Q3	$164K	Buy	37,622 +2,544	+7%	+$8.22K	﹤0.01%	5031
2022 Q2	$140K	Buy	35,078 +4,939	+16%	+$18.9K	﹤0.01%	5136
2022 Q1	$119K	Buy	30,139 +14,958	+99%	+$55.7K	﹤0.01%	5245
2021 Q4	$71K	Buy	15,181 +395	+3%	+$2.81K	﹤0.01%	5353
2021 Q3	$103K	Buy	+14,786	New	+$139K	﹤0.01%	5131

BlackRock's MIRO Position: Q4 2023 in Review

BlackRock sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2023, closing a stake of 56,042 shares — an estimated $73.4K sold.

BlackRock first reported a position in MIRO in Q3 2021 and held it in 9 quarters. The position peaked at $164K in Q3 2022. 0 funds tracked by Wall St. Rank hold MIRO as of Q4 2023.

BlackRock reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
BlackRock sold 56,042 Miromatrix Medical Inc. Common Stock shares in Q4 2023, an estimated $73.4K.
BlackRock first reported a position in Miromatrix Medical Inc. Common Stock in Q3 2021 and held it in 9 quarters.
BlackRock's Miromatrix Medical Inc. Common Stock position peaked at $164K in Q3 2022.
0 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2023.

Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.